논문상세정보
' Breast Cancer?Related Lymphedema after Neoadjuvant Chemotherapy' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • breast neoplasms
  • lymphedema
  • neoadjuvant chemotherapy
  • risk factors
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,733 0

0.0%

' Breast Cancer?Related Lymphedema after Neoadjuvant Chemotherapy' 의 참고문헌

  • Tumors induce complex DNA damage in distant proliferative tissues in vivo
    Redon CE Proc Natl Acad Sci U S A 107 : 17992 ~ 17997 [2010]
  • Tumors induce complex DNA damage in distant proliferative tissues in vivo
    Redon CE Proc Natl Acad Sci U S A 107 17992-17997 [2010]
  • The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer : a prospective cohort study
    Warren LE Int J Radiat Oncol Biol Phys 88 : 565 ~ 571 [2014]
  • The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer : a prospective cohort study
    Warren LE Int J Radiat Oncol Biol Phys 88 565-571 [2014]
  • Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer : the ACOSOG Z1071(Alliance)clinical trial
    Boughey JC JAMA 310 : 1455 ~ 1461 [2013]
  • Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer : the ACOSOG Z1071(Alliance)clinical trial
    Boughey JC JAMA 310 1455-1461 [2013]
  • Secondary lymphoedema after breast cancer surgery : a survival analysis
    Huang H Int J Nurs Pract 18 : 589 ~ 594 [2012]
  • Secondary lymphoedema after breast cancer surgery : a survival analysis
    Huang H Int J Nurs Pract 18 589-594 [2012]
  • Risk of lymphedema after regional nodal irradiation with breast conservation therapy
    Coen JJ Int J Radiat Oncol Biol Phys 55 : 1209 ~ 1215 [2003]
  • Risk of lymphedema after regional nodal irradiation with breast conservation therapy
    Coen JJ Int J Radiat Oncol Biol Phys 55 1209-1215 [2003]
  • Risk factors for lymphedema after breast cancer treatment
    Norman SA Cancer Epidemiol Biomarkers Prev 19 : 2734 ~ 2746 [2010]
  • Risk factors for lymphedema after breast cancer treatment
    Norman SA Cancer Epidemiol Biomarkers Prev 19 2734-2746 [2010]
  • Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients
    Specht MC Ann Surg Oncol 20 : 2835 ~ 2841 [2013]
  • Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients
    Specht MC Ann Surg Oncol 20 2835-2841 [2013]
  • Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy
    Le Scodan R Int J Radiat Oncol Biol Phys 82 : 1 ~ 7 [2012]
  • Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy
    Le Scodan R Int J Radiat Oncol Biol Phys 82 1-7 [2012]
  • Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer : a phase II trial
    Lee KS Invest New Drugs 28 : 83 ~ 90 [2010]
  • Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer : a phase II trial
    Lee KS Invest New Drugs 28 83-90 [2010]
  • Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer
    Bevilacqua JL Ann Surg Oncol 19 : 2580 ~ 2589 [2012]
  • Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer
    Bevilacqua JL Ann Surg Oncol 19 2580-2589 [2012]
  • Lymphedema in breast cancer survivors : incidence, degree, time course, treatment, and symptoms
    Norman SA J Clin Oncol 27 : 390 ~ 397 [2009]
  • Lymphedema in breast cancer survivors : incidence, degree, time course, treatment, and symptoms
    Norman SA J Clin Oncol 27 390-397 [2009]
  • Lymphedema following axillary lymph node dissection for breast cancer
    Sakorafas GH Surg Oncol 15 : 153 ~ 165 [2006]
  • Lymphedema following axillary lymph node dissection for breast cancer
    Sakorafas GH Surg Oncol 15 153-165 [2006]
  • Lymphedema after breast cancer : incidence, risk factors, and effect on upper body function
    Hayes SC J Clin Oncol 26 : 3536 ~ 3542 [2008]
  • Lymphedema after breast cancer : incidence, risk factors, and effect on upper body function
    Hayes SC J Clin Oncol 26 3536-3542 [2008]
  • Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
    Daveau C Int J Radiat Oncol Biol Phys 78 : 337 ~ 342 [2010]
  • Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
    Daveau C Int J Radiat Oncol Biol Phys 78 337-342 [2010]
  • Incidence of unilateral arm lymphoedema after breast cancer : a systematic review and meta-analysis
    DiSipio T Lancet Oncol 14 : 500 ~ 515 [2013]
  • Incidence of unilateral arm lymphoedema after breast cancer : a systematic review and meta-analysis
    DiSipio T Lancet Oncol 14 500-515 [2013]
  • Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study
    Clark B QJM 98 343-348 [2005]
  • Incidence and risk of arm oedema following treatment for breast cancer : a three-year follow-up study
    Clark B QJM 98 : 343 ~ 348 [2005]
  • Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation
    Shah C Int J Radiat Oncol Biol Phys 83 : 1095 ~ 1100 [2012]
  • Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation
    Shah C Int J Radiat Oncol Biol Phys 83 1095-1100 [2012]
  • Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer : findings from National Surgical Adjuvant Breast and Bowel Project B-18
    Fisher B J Clin Oncol 15 : 2483 ~ 2493 [1997]
  • Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer : findings from National Surgical Adjuvant Breast and Bowel Project B-18
    Fisher B J Clin Oncol 15 2483-2493 [1997]
  • Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?
    Hayes SB Int J Radiat Oncol Biol Phys 72 : 1449 ~ 1455 [2008]
  • Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?
    Hayes SB Int J Radiat Oncol Biol Phys 72 1449-1455 [2008]
  • A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Lee KS Breast Cancer Res Treat 109 : 481 ~ 489 [2008]
  • A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Lee KS Breast Cancer Res Treat 109 481-489 [2008]
  • A model to estimate the risk of breast cancer-related lymphedema : combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy
    Kim M Int J Radiat Oncol Biol Phys 86 : 498 ~ 503 [2013]
  • A model to estimate the risk of breast cancer-related lymphedema : combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy
    Kim M Int J Radiat Oncol Biol Phys 86 498-503 [2013]